Article Details
Retrieved on: 2022-05-14 11:12:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 3,678,334 shares of the biopharmaceutical company's stock valued at $1,096,000 after purchasing an additional 648,121 ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here